Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs
- PMID: 1685571
- DOI: 10.1055/s-2007-1014459
Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs
Similar articles
-
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.J Clin Psychiatry. 2003;64 Suppl 12:5-19. J Clin Psychiatry. 2003. PMID: 14640142
-
Drugs for psychotic disorders.Treat Guidel Med Lett. 2010 Aug;8(96):61-4; quiz two pages following last numbered page.. Treat Guidel Med Lett. 2010. PMID: 20651640 No abstract available.
-
Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.Nat Rev Drug Discov. 2006 Feb;5(2):133-46. doi: 10.1038/nrd1956. Nat Rev Drug Discov. 2006. PMID: 16518380 Review.
-
The CATIE study and its implications for antipsychotic drug use.Essent Psychopharmacol. 2006;7(1):53-63. Essent Psychopharmacol. 2006. PMID: 16989293 No abstract available.
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
Cited by
-
Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout.Clin Trials. 2021 Apr;18(2):237-244. doi: 10.1177/1740774520982315. Epub 2021 Jan 10. Clin Trials. 2021. PMID: 33426901 Free PMC article.
-
Recent developments in the management of psychosis.Pharm World Sci. 1998 Jun;20(3):101-6. doi: 10.1023/a:1008638805406. Pharm World Sci. 1998. PMID: 9618732 Review.
-
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia.Psychopharmacology (Berl). 1994 Jun;115(1-2):221-8. doi: 10.1007/BF02244775. Psychopharmacology (Berl). 1994. PMID: 7862898 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical